Amplifier Therapeutics

Biotechnology Research • United States • 1-10 Employees

Company overview

Headquarters	United States
Website	amplifier-tx.com
Employees	1-10
Socials

Key Contact at Amplifier Therapeutics

James Hall

Chief Executive Officer

About Amplifier Therapeutics

Amplifier Therapeutics, a Cambrian Bio PipeCo, is focused on the development of AMP-activated protein kinase (AMPK) activator compounds to treat diseases associated with aging including metabolic conditions, cardiovascular diseases, kidney diseases, and cancer. As a Distributed Development Company (or DisCo), Cambrian is advancing multiple scientific breakthroughs, each targeting a biological driver of aging. Our approach is to develop interventions that treat specific diseases first, then deploy them as preventative medicines to improve quality of life/overall quality of life as we age.

Amplifier Therapeutics revenue & valuation

Annual revenue	$300,000
Revenue per employee	$150,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$960,000
Total funding	No funding

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

Amplifier Therapeutics has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Amplifier Therapeutics has never raised funding before.